The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms

Author： Daniel Włladyslława Anna  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.2, 2005-08, pp. : 203-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 and Anticancer Drugs

By  

Current Drug Metabolism, Vol. 7, Iss. 1, 2006-01 ,pp. : 23-37

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric   Legendre Christopher   Beaune Philippe   Anglicheau Dany  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

By Schaik Ron  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 513-522

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response

By Tsai Ming-Hsien   Lin Keh-Ming   Hsiao Mei-Chun   Shen Winston W   Lu Mong-Liang   Tang Hwa-Sheng   Fang Chun-Kai   Wu Chi-Shin   Lu Shao-Chun   Liu Shu Chih   Chen Chun-Yu   Liu Yu-Li  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 537-546

Future Medicine

Access to resources Recommend Favorite

“Drugs on oxygen”: an update and perspective on the role of cytochrome P450 testing in pharmacology

By Tralau Tewes   Luch Andreas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1357-1362

Informa Healthcare

Access to resources Recommend Favorite